NRXS vs OM: stock comparison and AI forecast
Neuraxis, Inc (NRXS) and Outset Medical, Inc. (OM) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
NRXS Neuraxis, Inc
- Market Cap
- $77M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
OM Outset Medical, Inc.
- Price
- $4.15 -13.0% · 6M
- Market Cap
- $77M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- NRXS and OM have similar market capitalizations ($77M and $77M).
- OM carries 1.77 times debt per unit of equity, against 0.48 times for NRXS.
- Both companies share the SEC industry classification Electromedical & Electrotherapeutic Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | NRXS | OM |
|---|---|---|
| Market Cap | $77M | $77M |
| P/B Ratio | 11.39x | 0.93x |
| EPS | $-0.92 | $-2.45 |
| Book Value/Share | $0.54 | $4.43 |
| Revenue/Share | $0.42 | $6.49 |
| FCF/Share | – | $-2.28 |
Profitability & Margins
| Metric | NRXS | OM |
|---|---|---|
| ROE | -114.0% | – |
| ROA | -76.8% | – |
| ROIC | -111.3% | -33.6% |
| Gross Margin | 85.6% | 42.0% |
| Operating Margin | -144.5% | -51.2% |
| Net Margin | -144.4% | – |
| EBT Margin | -144.5% | -57.8% |
| Tax Rate | -0.3% | -1.0% |
Financial Health
| Metric | NRXS | OM |
|---|---|---|
| Current Ratio | 3.04x | 4.86x |
| Quick Ratio | 2.95x | 3.85x |
| D/E Ratio | 0.48x | 1.77x |
| Financial Leverage | 1.48x | 2.77x |
| Interest Coverage | -107.3x | -3.5x |
| Working Capital | $6M | $172M |
Cash Flow
| Metric | NRXS | OM |
|---|---|---|
| Operating Cash Flow | -$6M | -$42M |
| Free Cash Flow | – | -$43M |
| Capital Spending | – | -$510K |
| FCF/Sales | – | -35.2% |
| CapEx/Sales | – | 0.4% |
Operational Efficiency
| Metric | NRXS | OM |
|---|---|---|
| Asset Turnover | 0.53x | 0.53x |
| Receivables Turnover | 12.3x | 4.0x |
| Inventory Turnover | 2.8x | 1.6x |
| Fixed Assets Turnover | 81.2x | 34.4x |
| Days Sales Outstanding | 30 days | 91 days |
| Days Inventory | 132 days | 232 days |
| Payables Period | 376 days | 22 days |
| Cash Conversion Cycle | -215 days | 301 days |
Income Statement
| Metric | NRXS | OM |
|---|---|---|
| Total Revenue | $5M | $122M |
| Operating Income | -$8M | -$62M |
| Net Income | -$8M | – |
| R&D Expense | $750K | $22M |
| SG&A Expense | $11M | $116M |
| Cost of Goods Sold | $770K | $71M |
Dividend & Shareholder Information
| Metric | NRXS | OM |
|---|---|---|
| Shares Outstanding | 13M | 19M |
NRXS vs OM: stock comparison and AI forecast
Which is bigger, NRXS or OM?
NRXS and OM have similar market capitalizations ($77M and $77M).
Which one does Intratio's AI model rank higher, NRXS or OM?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.